Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Cromer

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
International Journal for Parasitology|September 4, 2018
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in miceRosemary A Aogo, David S Khoury, Deborah Cromer, et al.
Immunity|June 11, 2022
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variantsMarios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Cell Reports. Medicine|May 17, 2021
Decay of Fc-dependent antibody functions after mild to moderate COVID-19Wen Shi Lee, Kevin John Selva, Samantha K Davis, et al.
Epidemics|July 17, 2020
Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challengesAmani Alahmadi, Sarah Belet, Andrew Black, et al.
JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Plos Pathogens|February 28, 2019
Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cellsJasmin Akter, David S Khoury, Rosemary Aogo, et al.
Science Advances|July 21, 2023
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infectionWen Shi Lee, Hyon-Xhi Tan, Arnold Reynaldi, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infectionSandile Cele, Laurelle Jackson, David S Khoury, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
International Journal for Parasitology|September 4, 2018
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in miceRosemary A Aogo, David S Khoury, Deborah Cromer, et al.
Immunity|June 11, 2022
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variantsMarios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Cell Reports. Medicine|May 17, 2021
Decay of Fc-dependent antibody functions after mild to moderate COVID-19Wen Shi Lee, Kevin John Selva, Samantha K Davis, et al.
Epidemics|July 17, 2020
Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challengesAmani Alahmadi, Sarah Belet, Andrew Black, et al.
JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Plos Pathogens|February 28, 2019
Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cellsJasmin Akter, David S Khoury, Rosemary Aogo, et al.
Science Advances|July 21, 2023
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infectionWen Shi Lee, Hyon-Xhi Tan, Arnold Reynaldi, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
Nature Communications|February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infectionSandile Cele, Laurelle Jackson, David S Khoury, et al.
Pageof 9